Pepticom is pleased to welcome Dr. Waleed Danho to its Scientific Advisory Board

Pepticom is pleased to welcome Dr. Waleed Danho to its Scientific Advisory Board. Dr. Waleed Danho held the position of Distinguished Research Leader at Hoffmann-La Roche Inc. in Nutley, New Jersey, USA. until April 2011. He is a reviewer for the Journal of Peptide Research, QSAR & Combinatorial Science and the Journal of Medicinal Chemistry; […]

Pepticom is delighted to present our latest publication in the Journal of Immunology

Pepticom is delighted to present our latest article, published in the Journal of Immunology, on the subject of Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity. To the best of our knowledge, this is the first example of using Artificial Intelligence for the discovery of novel cyclic peptides; the discovery effort yielded 53 […]

Pepticom is pleased to announce that Pierre Riviere, Ph.D., has joined the company’s Scientific Advisory Board to advise Pepticom on its peptide therapeutics strategy, programs and business.

Dr. Riviere has over 25 years of biopharmaceutical industry experience with R&D leadership roles in target and drug discovery, nonclinical and early-stage clinical development. He is a recognized expert in peptide therapeutics with both established peptide modalities and emerging novel peptide technologies. Dr. Riviere is Founder and CEO of Peptide Logic, a San Diego-based biotech […]